Literature DB >> 10971506

Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

P E Brenchley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10971506      PMCID： PMC1905731          DOI： 10.1046/j.1365-2249.2000.01299.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  54 in total

Review 1.  Angiogenesis.

Authors:  J Folkman; Y Shing
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.

Authors:  J E Turnbull; D G Fernig; Y Ke; M C Wilkinson; J T Gallagher
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

3.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

Authors:  C K Goldman; J Kim; W L Wong; V King; T Brock; G Y Gillespie
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

4.  Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

Authors:  M A Goldberg; T J Schneider
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

5.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

6.  Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells.

Authors:  G T Stavri; Y Hong; I C Zachary; G Breier; P A Baskerville; S Ylä-Herttuala; W Risau; J F Martin; J D Erusalimsky
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

7.  Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells.

Authors:  J Li; M A Perrella; J C Tsai; S F Yet; C M Hsieh; M Yoshizumi; C Patterson; W O Endege; F Zhou; M E Lee
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

8.  Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.

Authors:  A E Koch; L A Harlow; G K Haines; E P Amento; E N Unemori; W L Wong; R M Pope; N Ferrara
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

9.  Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.

Authors:  L Pertovaara; A Kaipainen; T Mustonen; A Orpana; N Ferrara; O Saksela; K Alitalo
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Authors:  R A Fava; N J Olsen; G Spencer-Green; K T Yeo; T K Yeo; B Berse; R W Jackman; D R Senger; H F Dvorak; L F Brown
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307
View more
  8 in total

Review 1.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: a meta-analysis.

Authors:  Min Qi; Xiaoyuan Huang; Lei Zhou; Jianglin Zhang
Journal:  DNA Cell Biol       Date:  2014-04       Impact factor: 3.311

3.  Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients.

Authors:  Yeon-Ah Lee; Jung Yeon Kim; Seung-Jae Hong; Sang-Hoon Lee; Myung Chul Yoo; Kyoung Soo Kim; Hyung-In Yang
Journal:  Clin Rheumatol       Date:  2007-03-29       Impact factor: 2.980

4.  Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms.

Authors:  Sergio Sánchez-Enríquez; Nora Magdalena Torres-Carrillo; Mónica Vázquez-Del Mercado; Lorenzo Salgado-Goytia; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

5.  The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor.

Authors:  F Biscetti; A Flex; G Pecorini; F Angelini; V Arena; E Stigliano; E Gremese; B Tolusso; G Ferraccioli
Journal:  Clin Exp Immunol       Date:  2016-01-19       Impact factor: 4.330

Review 6.  Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky.

Authors:  Jim Middleton; Laure Americh; Regis Gayon; Denis Julien; Luc Aguilar; Francois Amalric; Jean-Philippe Girard
Journal:  Arthritis Res Ther       Date:  2004-03-08       Impact factor: 5.156

Review 7.  Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis.

Authors:  Anja K Weidemann; Ania A Crawshaw; Emily Byrne; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-09-26

8.  Intervening upregulated SLC7A5 could mitigate inflammatory mediator by mTOR-P70S6K signal in rheumatoid arthritis synoviocytes.

Authors:  Jing Xu; Congshan Jiang; Yongsong Cai; Yuanxu Guo; Xipeng Wang; Jiaxiang Zhang; Jiawen Xu; Ke Xu; Wenhua Zhu; Si Wang; Fujun Zhang; Manman Geng; Yan Han; Qilan Ning; Peng Xu; Liesu Meng; Shemin Lu
Journal:  Arthritis Res Ther       Date:  2020-08-31       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.